CSA Medical, Inc. has been funded with $55 million from a diverse equity base of over 100 venture and private investors including leaders in life sciences and medical device technology. Select investors include:
Ascension Ventures is a strategic healthcare venture fund with $550 million in capital under management. Ascension Ventures’ limited partners are some of the most respected, values-driven nonprofit healthcare systems in the US. As a strategic investor, Ascension Ventures adds value by sharing its portfolio companies’ solutions across its limited partner base. The work we do at Ascension Ventures generates returns to our limited partners that help support their missions to provide care to the poor and vulnerable.
SV Life Sciences
SV Life Sciences (SVLS) is a leading international life sciences venture capital firm. SVLS affiliated funds have been investing in life sciences companies since the early 1980s and the firm closed its first dedicated life sciences fund in 1994. The SVLS team manages five private venture capital funds with approximately $2.0 billion of capital under management. The firm employs a diversified strategy within life sciences in order to selectively capitalize on an expanding opportunity in biotech, medical devices and healthcare services. SVLS has offices in Boston, London and San Francisco.
Based in Durham, North Carolina, Intersouth Partners is one of the most active venture capital firms in the Southeast, having invested in more than 100 private companies. Founded in 1985, the firm seeks a broad range of investment opportunities in the technology and life science sectors. Intersouth manages $780 million in seven venture capital limited partnerships, making it the largest venture capital fund in North Carolina and one of the largest in the Southeast.
First Analysis is a leading private growth equity investor with 27 years of experience in private capital investing. The firm invests mainly in the United States with a focus on health care productivity, broadband enabled businesses and clean-tech / infrastructure. Having invested $700 million across multiple highly diversified funds, First Analysis invests for growth in small and mid-size companies with established business models, high internal growth rates, and large-market leadership potential.
Rose Park Advisors
Based in Boston, MA, Rose Park Advisors, LLC is a specialized investment firm focused on identifying investment opportunities by applying the frameworks of disruptive innovation, developed by its co-founder, Professor Clayton Christensen. Rose Park Advisors applies these frameworks to identify companies whose business model is well suited to take advantage of evolving industry dynamics, regardless of the company’s size, industry, or geography.
Blue Heron Capital
Based in Richmond, Virginia, Blue Heron Capital manages an exclusive group of approximately 40 active investors in the mid-Atlantic. The Blue Heron team seeks opportunities where investors can obtain outstanding financial returns by primarily investing in early-stage, growth, and buy-out opportunities. The firm brings strategic capital, industry expertise and a powerful network to support companies.
Series A/B Preferred Private Investor Trustees
Robb Doub – New Markets Venture Partners
Richard Schwarz – Edgewater Capital Partners
Peter Rubin, Esq. – Atlantic Capital Group
Series C Preferred Private Investor Trustees
Scott Kokones – Guide Medical Ventures
Steven Peck – SAP